APA (7th ed.) Citation

Kuca, B., Silberstein, S. D., Wietecha, L., Berg, P. H., Dozier, G., & Lipton, R. B. (2018). Lasmiditan is an effective acute treatment for migraine: A phase 3 randomized study. Neurology, 91(24), e2222. https://doi.org/10.1212/WNL.0000000000006641

Chicago Style (17th ed.) Citation

Kuca, Bernice, Stephen D. Silberstein, Linda Wietecha, Paul H. Berg, Gregory Dozier, and Richard B. Lipton. "Lasmiditan Is an Effective Acute Treatment for Migraine: A Phase 3 Randomized Study." Neurology 91, no. 24 (2018): e2222. https://doi.org/10.1212/WNL.0000000000006641.

MLA (9th ed.) Citation

Kuca, Bernice, et al. "Lasmiditan Is an Effective Acute Treatment for Migraine: A Phase 3 Randomized Study." Neurology, vol. 91, no. 24, 2018, p. e2222, https://doi.org/10.1212/WNL.0000000000006641.